These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7532630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV.
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [Abstract] [Full Text] [Related]

  • 3. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.
    McCool TL, Harding CV, Greenspan NS, Schreiber JR.
    Infect Immun; 1999 Sep; 67(9):4862-9. PubMed ID: 10456942
    [Abstract] [Full Text] [Related]

  • 4. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
    Mawas F, Feavers IM, Corbel MJ.
    Vaccine; 2000 Dec 08; 19(9-10):1159-66. PubMed ID: 11137252
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection.
    Könen-Waisman S, Cohen A, Fridkin M, Cohen IR.
    J Infect Dis; 1999 Feb 08; 179(2):403-13. PubMed ID: 9878025
    [Abstract] [Full Text] [Related]

  • 8. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
    Lefeber DJ, Benaissa-Trouw B, Vliegenthart JF, Kamerling JP, Jansen WT, Kraaijeveld K, Snippe H.
    Infect Immun; 2003 Dec 08; 71(12):6915-20. PubMed ID: 14638780
    [Abstract] [Full Text] [Related]

  • 9. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL, Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Madore D.
    Pediatr Infect Dis J; 1996 May 08; 15(5):425-30. PubMed ID: 8724065
    [Abstract] [Full Text] [Related]

  • 10. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
    Shapiro DA, Threadgill DS, Copfer MJ, Corey DA, McCool TL, McCormick LL, Magnuson TR, Greenspan NS, Schreiber JR.
    J Immunol; 1998 Oct 01; 161(7):3393-9. PubMed ID: 9759856
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.
    Barrios C, Lussow AR, Van Embden J, Van der Zee R, Rappuoli R, Costantino P, Louis JA, Lambert PH, Del Giudice G.
    Eur J Immunol; 1992 Jun 01; 22(6):1365-72. PubMed ID: 1601031
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.
    Fernández IM, Snijders A, Benaissa-Trouw BJ, Harmsen M, Snippe H, Kraaijeveld CA.
    J Virol; 1993 Oct 01; 67(10):5843-8. PubMed ID: 7690411
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen.
    Könen-Waisman S, Fridkin M, Cohen IR.
    J Immunol; 1995 Jun 01; 154(11):5977-85. PubMed ID: 7538539
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
    Hiranuma K, Tamaki S, Nishimura Y, Kusuki S, Isogawa M, Kim G, Kaito M, Kuribayashi K, Adachi Y, Yasutomi Y.
    J Gen Virol; 1999 Jan 01; 80 ( Pt 1)():187-193. PubMed ID: 9934701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.